JAX and NYSCF leaders, public officials, and supporters at the JAX-NYSCF ribbon tying event on Dec. 17. [The Jackson Laboratory] The Jackson Laboratory (JAX) and the New York Stem Cell Foundation ...

Abstract: Deep learning's power model is evaluated for classifying genomic regions as cancerous or non-cancerous depends on copy number variation (CNV) patterns in cervical cancer, using ...

The Department of Health and Human Services is tapping the Jackson Laboratory to expand testing using lab-grown cells and artificial intelligence, following the lab's acquisition of the New York Stem ...

A small group of patients with an otherwise incurable form of T‑cell leukemia have seen their cancer driven into remission by an innovative form of immune therapy. Sensitive tests designed to detect ...

Texas A&M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower particles. These energized stem cells then transfer their surplus “power packs” ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

The New York Stem Cell Foundation, a $23-million-a-year biomedical nonprofit, was acquired by the Jackson Laboratory as part of a move to expand automation in life sciences research. The acquisition, ...

Jackson Laboratory, a genetics and genomic medicine organization headquartered in Bar Harbor, completed its acquisition of the New York Stem Cell Foundation, a nonprofit that developed an AI platform ...

New integrated platform will transform early-stage research, equipping scientists worldwide to uncover disease mechanisms earlier and advance progress toward therapies for Alzheimer's, cancer, ...